| 1 | GB-0998 For Unexplained Recurrent Miscarriage | 2023-005-S |  |
| 2 | Airway Shield | 2023-004-S | |
| 3 | Capivasertib For Breast Cancer | 2023-002-B | |
| 4 | Baxdrostat In Patients With Resistant Hypertension | 2023-001-S | |
| 5 | Aprocitentan In Patients With Resistant Hypertension | 2023-001-B | |
| 6 | Tirzepatide For Treatment Of Obesity | 2022-010-S | |
| 7 | Oral Medication For Treatment Of Obstructive Sleep Apnoea | 2022-010-B | |
| 8 | The Mirvie RNA Platform For Early Detection Of Pre-Eclampsia | 2022-009-S | |
| 9 | GammaSense for Alzheimer's disease | 2022-009-B | |
| 10 | Extravascular Implantable Cardioverter-Defibrillator | 2022-008-B | |
| 11 | Obefazimod (ABX464) For The Treatment Of Ulcerative Colitis | 2022-007-B | |
| 12 | Nirsevimab For Prevention Of Respiratory Syncytial Virus In Infants | 2022-006-B | |
| 13 | Etrolizumab For Inflammatory Bowel Disease | 2022-005-S | |
| 14 | Rewalk Reboot Soft Exoskeleton Device In Stroke Paraplegia Patients | 2022-005-B | |
| 15 | Tebipenem Pivoxil Hydrobromide In Complicated Urinary Tract Infection | 2022-004-S | |
| 16 | Automated Virtual Reality Cognitive Therapy (Gamechange) For Agoraphobia Among Psychiatric Patients | 2022-004-B | |
| 17 | Automated Virtual Reality Cognitive Therapy (gameChange) for Agoraphobia among Psychiatric Patients | 2022-004-B | |
| 18 | Peripheral Blood Stem Cell (PBSC) For Articular Cartilage Regeneration (An Update) | 2022-003-S | |
| 19 | Lecanemab (BAN2401) For Alzheimer's Disease | 2022-003-B | |
| 20 | Zatolmilast (BPN14770) For The Treatment Of Fragile X Syndrome | 2022-002-S | |
| 21 | Ensifentrine (RPL 554) For The Treatment Of Chronic Obstructive Pulmonary Disease (COPD) | 2022-002-B | |
| 22 | Iptacopan For The Treatment Of C3 Glomerulopathy | 2022-001-S | |
| 23 | Daprodustat For Anaemia In Chronic Kidney Disease (CKD) | 2022-001-B | |
| 24 | Pembrolizumab For Adjuvant Treatment Of Post-Nephrectomy In Renal Cell Carcinoma Patients | 2021-011-S | |
| 25 | Efpeglenatide For Renal And Cardiovascular Protection In Type II Diabetes | 2021-010-S | |